AVEO Oncology
AVEO
#7394
Rank
ยฃ0.39 B
Marketcap
ยฃ11.45
Share price
0.00%
Change (1 day)
170.08%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -ยฃ22.91 Million

According to AVEO Oncology 's latest financial reports the company's current earnings are ยฃ94.31 Million. In 2021 the company made an earning of -ยฃ40.74 Million a decrease over its 2020 earnings that were of -ยฃ27.18 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -ยฃ22.91 Million-43.76%
2021 -ยฃ40.74 Million49.9%
2020 -ยฃ27.18 Million-479.04%
2019 ยฃ7.16 M-276.17%
2018 -ยฃ4.07 Million-91.79%
2017 -ยฃ49.58 Million142.38%
2016 -ยฃ20.46 Million78.51%
2015 -ยฃ11.46 Million-71.55%
2014 -ยฃ40.28 Million-50.72%
2013 -ยฃ81.74 Million-4.88%
2012 -ยฃ85.93 Million-426.29%
2011 ยฃ26.33 M-159.85%
2010 -ยฃ44.01 Million35.33%
2009 -ยฃ32.52 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
ยฃ26.55 B-119,832.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ8.43 B-38,159.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ0.33 B-1,632.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
ยฃ4.34 B-19,683.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ8.65 B-39,123.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-ยฃ1.73 Million-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA